🦊/Companies

Tissium

4 known investors

Find your way into Tissium

TISSIUM develops biomorphic polymer technology, including proprietary polymers, activation technologies, and delivery devices, to reconstruct damaged tissue and restore its function across multiple therapeutic areas. The company operates an integrated innovation, design, manufacturing, and commercialization platform serving its own programs and co-development partnerships in the medtech industry.

Founders & leadership

CBChristophe Bancel
Christophe BancelinCo-founder & CEO
MPMaria Pereira
Maria PereirainCo-inventor of the technology; leads the Innovation Hub

Investors · 4

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 3

by search overlap

Companies competing with Tissium for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Tissium do?
TISSIUM develops biomorphic polymer technology, including proprietary polymers, activation technologies, and delivery devices, to reconstruct damaged tissue and restore its function across multiple therapeutic areas. The company operates an integrated innovation, design, manufacturing, and commercialization platform serving its own programs and co-development partnerships in the medtech industry.
Who founded Tissium?
Tissium was founded by Christophe Bancel, Maria Pereira.
Who are Tissium's investors?
Tissium's investors include Cathay Health, Karista, Sofinnova Partners, European Investment Bank.